Mekinist Drug Insight Report 2018: MOA, Target, Dosage, Route of Administration, Molecule Type, Strength, Chemical Type and ATC Classification - ResearchAndMarkets.com

DUBLIN--()--The "Mekinist - Drug Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Mekinist Drug Insight, 2018' highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.

The report covers the Global Market Assessment of the Mekinist covering the historical global sales and also provides the Mekinist sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Mekinist and emerging therapies in this space.

Key Topics Covered:

1. Introduction

2. Mekinist- Overview

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Regulatory Milestones by Region
  • Deals and Partnerships

3. Product Details

4. Mekinist Sales Assessment

  • Historical Sales
  • Forecasted Sales

5. Patent Details

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

7. Market Competition

8. Emerging Therapies

  • Product Description
  • Research and Development
  • Product Development Activities

9. SWOT Analysis

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/pt5hpz/mekinist_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs